Physician profile
Michael Wood
NPI 1659391548
$1,492.83
in general payments reported to CMS, 2019-2025
14 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $226 · 2021: $166 · 2022: $109 · 2023: $318 · 2024: $16.13 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $638.06 | 2019-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Atricure, INC. | $240.00 | 2019-2020 | |
| Shockwave Medical, INC | $191.95 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Ethicon US, LLC | $130.86 | 2021-2025 | Vistaseal, Evarrest, Mega Soft |
| Immunitybio, INC. | $68.52 | 2025 | |
| Cvrx, INC. | $55.78 | 2023 | Barostim Neo System |
| Silk Road Medical, INC. | $47.42 | 2021 | |
| Laborie Medical Technologies Corp. | $31.07 | 2022-2023 | |
| Inari Medical, INC. | $19.64 | 2021 | |
| Baxter Healthcare | $18.99 | 2023 | Preveleak |
| Tolmar Pharmaceuticals, INC. | $16.26 | 2020 | |
| Medtronic, INC. | $14.35 | 2022 | |
| Medtronic Vascular, INC. | $13.33 | 2020 | |
| Cardiovascular Systems INC. | $6.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.